Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

NCT01497262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Fingolimod

Sponsor

Novartis Pharmaceuticals